Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy-Reference-Cited by-同舟云学术

Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy

Published:2009-11 Issue:3 Volume:147 Page:408-410
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Intermesoli Tamara,Shamash Jonathan,Rohatiner Ama,Wilson Andrew,Lister Andrew,Montoto Silvia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07847.x/fullpdf

Reference10 articles.

1. Modern treatment of Hodgkin lymphoma;Bartlett;Current Opinion in Hematology,2008

2. Relapsed and refractory Hodgkin’s lymphoma: new avenues?;Canellos;Hematology/oncology Clinics of North America,2007

3. Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy;Coleman;Cancer,2008

4. Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide;Haim;Cancer Chemotherapy and Pharmacology,1995

5. Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study;Helsing;European Journal of Cancer,1997

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Paclitaxel Efficacy to Suppress Triple-Negative Breast Cancer Progression Using Metronomic Chemotherapy with a Controlled Release System of Electrospun Poly-d-l-Lactide-Co-Glycolide (PLGA) Nanofibers;Cancers;2021-07-03